FLGT

FLGT

USD

Fulgent Genetics Inc. Common Stock

$20.540+2.340 (12.857%)

Real-time Price

Healthcare
Diagnostics & Research
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$18.200

High

$20.940

Low

$17.925

Volume

0.07M

Company Fundamentals

Market Cap

634.0M

Industry

Diagnostics & Research

Country

United States

Trading Stats

Avg Volume

0.48M

Exchange

NGM

Currency

USD

52-Week Range

Low $14.57Current $20.540High $25.11

AI Analysis Report

Last updated: May 2, 2025
AI-GeneratedData Source: Yahoo Finance, Bloomberg, SEC

FLGT: Fulgent Genetics Inc. Common Stock - Analyzing Recent Moves & What Might Come Next

Stock Symbol: FLGT Generate Date: 2025-05-02 10:50:18

Alright, let's break down what's happening with Fulgent Genetics (FLGT) based on the latest info we've got. Think of this as figuring out the story the stock is telling us right now.

Recent News Buzz: What's the Vibe?

The main piece of news we have is pretty straightforward: Fulgent is set to announce its first-quarter 2025 financial results today, May 2nd. This isn't news about what the results are, just that they're coming.

Now, interestingly, the sentiment data tied to this stock suggests the recent news vibe is actually quite positive. Even though the announcement itself is neutral, the market seems to be feeling optimistic about it. Maybe folks are anticipating good numbers, or perhaps there's other positive chatter out there we don't see directly. The key takeaway here is that a big event (earnings) is happening right now, and the general feeling around it seems upbeat, at least according to the sentiment analysis.

Price Check: What's the Stock Been Doing?

Looking back over the last month or so, FLGT's price has been on a bit of a rollercoaster, but with a general upward tilt until very recently. It started February around $16 and change, saw a nice jump in early March, hitting highs near $19. Then it bounced around, mostly between $16.50 and $19. The last few trading days, though, show a slight dip, pulling back from around $19 down to about $17.25 as of yesterday's close (May 1st).

So, the price has cooled off a little just before the big earnings announcement today.

Now, let's peek at the AI's crystal ball for the next couple of days. The AI predicts the price will stay flat today (0.00% change), which makes sense given everyone's waiting for the earnings news. But then, it sees the price potentially climbing: up 1.82% tomorrow and another 2.22% the day after. This suggests the AI expects a positive reaction after the earnings dust settles today.

Putting It Together: Outlook & Ideas

Based on the news of the earnings announcement happening today, the generally positive sentiment surrounding it, the recent slight price pullback, and the AI's prediction of upward movement after today, the near-term picture seems to lean cautiously positive, especially looking past today's immediate reaction.

Today is the wildcard because of the earnings release. The AI thinks it'll be flat, but earnings can cause big swings either way depending on the actual numbers and guidance.

If you're thinking about this stock, here's how you might look at it based on this data:

  • The Big Event: Earnings are today. This is the main driver right now.
  • Potential Entry Consideration: The recommendation data points to potential entry areas around $17.32 or $17.46. These are right around where the stock closed yesterday ($17.25). Given the AI predicts upward movement after today, one strategy could be to wait and see how the market reacts to the earnings news today. If the reaction is positive and the price starts moving up, entering around these levels after the news is out might be something to consider. Entering before earnings is a gamble on the outcome.
  • Potential Risk Management: The recommendation data suggests a stop-loss level at $15.53. This is a good bit below recent prices and acts as a level to potentially cut losses if the stock takes a significant turn for the worse, perhaps due to disappointing earnings or broader market issues. It's smart to have a plan for what you'll do if things don't go as hoped.

Remember, the company itself is involved in both lab services (like genetic testing) and developing new therapies. So, the earnings report today will give us a look into how both sides of their business are doing.

Company Context

Just a quick note on Fulgent itself: They're in the Healthcare sector, specifically Diagnostics & Research. They do a mix of things, from standard lab tests to genetic sequencing and even drug development. This mix means their results can be influenced by different factors in the healthcare world. The earnings report today will cover all of this.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Related News

Analyst Upgrades

Raymond James Reiterates Outperform on Fulgent Genetics, Raises Price Target to $25

Raymond James analyst Andrew Cooper reiterates Fulgent Genetics with a Outperform and raises the price target from $24 to $25.

View more
Raymond James Reiterates Outperform on Fulgent Genetics, Raises Price Target to $25
BusinessWire

Fulgent Reports First Quarter 2025 Financial Results

Core Revenue of $73.5 million grows 16% year-over-year Reiterating Full Year 2025 Core Revenue Guidance of $310 million Non-GAAP income of $1.2 million, or $0.04 per share; GAAP loss of $11.5 million, or ($0.37)

View more
Fulgent Reports First Quarter 2025 Financial Results

AI PredictionBeta

AI Recommendation

Bullish

Updated at: May 5, 2025, 01:52 PM

BearishNeutralBullish

63.3% Confidence

Risk & Trading

Risk Level3/5
Medium Risk
Suitable For
Value
Trading Guide

Entry Point

$20.63

Take Profit

$22.10

Stop Loss

$18.49

Key Factors

DMI shows bearish trend (ADX:13.5, +DI:17.8, -DI:17.9), suggesting caution
Current Price is extremely close to support level ($20.58), suggesting strong buying opportunity
Trading volume is 10.0x average (5,006), indicating extremely strong buying pressure
MACD 0.0055 is below signal line 0.0329, indicating a bearish crossover

Stay Updated

Set price alerts, get AI analysis updates and real-time market news.